Back to Career News

GSK selling stake in Hindustan Unilever

May 07, 2020

GSK selling stake in Hindustan Unilever

GlaxoSmithKline is selling $3.45 billion worth of shares in Hindustan Unilever at the open marketplace, in keeping with a deal marketing term sheet seen by Reuters, cashing in late from the sale of the Horlicks brand.

The 5.7% stake in Hindustan Unilever that is now in the marketplace turned into every day by means of GSK as payment for the sale of the malted drink brand and various Nutrition brands to Hindustan Unilever.

The cash injection will assist GSK in its goal of strengthening its drug development pipeline, having made steeply-priced bets on experimental most cancers remedies and future cell and gene therapies during gradual sales increase.

Recommended for you ...

Axis Bank and Mastercard Launch Premium Credit Card for Small Business Owners
Axis Bank and Mastercard Launch Premium Credit Card for Small Business Owners

September 26, 2024

Banks Report Over 15% Growth in New Credit Card Additions: RBI Data
Banks Report Over 15% Growth in New Credit Card Additions: RBI Data

September 26, 2024

National Company Law Tribunal (NCLT) Approves Merger of IDFC and IDFC First Bank
National Company Law Tribunal (NCLT) Approves Merger of IDFC and IDFC First Bank

September 25, 2024

Chat on WhatsApp